Interleukin IL-1B gene polymorphism in Tunisian patients with chronic hepatitis B infection: Association with replication levels

• Published in: Microbiology and immunology Vol. 64; no. 7; p. 512
• Main Authors: Ben Dhifallah, Imen, Ayouni, Kaouther, Najjar, Ghofrane, Chelbi, Hanene, Sadraoui, Amel, Hammami, Walid, Touzi, Henda, Triki, Henda
• Format: Journal Article
• Language: English
• Published: Australia 01.07.2020
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Female; Gene Frequency; Genetic Predisposition to Disease - epidemiology; Genotype; Hepatitis B, Chronic - epidemiology; Hepatitis B, Chronic - genetics; Humans; Interleukin-1beta - genetics; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Tunisia; Young Adult; Tunisia; viral load levels; polymorphism; IL-1B; hepatitis B virus; polymerase chain reaction
• ISSN: 1348-0421
• DOI: 10.1111/1348-0421.12774

Approaches based on association studies have proven useful in identifying genetic predictors for many diseases, including susceptibility to chronic hepatitis B. In this study we were interested by the IL-1B genetic variants that have been involved in the immune response and we analyzed their role in the susceptibility to develop chronic hepatitis B in the Tunisian population. IL-1B is a potent proinflammatory cytokine that plays an important role in inflammation of the liver. Polymorphic gene IL-1 (-511, +3954) was analyzed in a total of 476 individuals: 236 patients with chronic hepatitis B from different cities of Tunisia recruited in Pasteur Institute between January 2017 and December 2018 and 240 controls. Genomic DNA was obtained using the standard salting-out method and genotyping was performed by polymerase chain reaction (PCR)-restriction fragment length polymorphism. For -511C>T polymorphism a significant association was found between patients and controls when comparing the genotypic (P = 0.007; χ  = 9.74 and odds ratio [OR] = 0.60; confidence interval [CI] = 0.41-0.89) and allelic (P = 0.001; χ  = 10.60) frequencies. When the viral load was taken into account a highly significant difference was found (P = 9 × 10 ; χ  = 10.89). For +3954C>T polymorphism a significant association was found between patients and controls when comparing genotypic (P = 0.0058; χ  = 7.60 and OR = 1.67; CI = 1.14-2.46) and allelic (P = 0.0029; χ  = 8.81) frequencies. T allele can be used as a strong marker for hepatitis B virus disease for both polymorphisms.